Jared M. Worful is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody conjugates. With a total of 6 patents to his name, Worful's work has the potential to impact therapeutic applications significantly.

Latest Patents

One of Worful's latest patents is focused on the "Preparation of maytansinoid antibody conjugates by a one-step process." This invention provides a streamlined method for preparing a cell-binding agent cytotoxic agent conjugate. The process involves contacting a cell-binding agent with a cytotoxic agent to form a first mixture. This mixture is then treated with a bifunctional crosslinking reagent in a solution with a pH of about 4 to about 9. The result is a second mixture that comprises the cell-binding agent cytotoxic agent conjugate, which can be purified to yield a refined product. This innovative approach enhances the efficiency of creating effective therapeutic agents.

Career Highlights

Worful is currently employed at Immunogen, Inc., where he continues to advance his research and development efforts. His work at the company has positioned him as a key player in the field of antibody-drug conjugates, which are crucial for targeted cancer therapies.

Collaborations

Worful has collaborated with several professionals in his field, including Xinfang Li. These collaborations have fostered an environment of innovation and have contributed to the successful development of new technologies.

Conclusion

Jared M. Worful's contributions to the field of biotechnology through his patents and work at Immunogen, Inc. highlight his role as an influential inventor. His innovative approaches to antibody conjugates are paving the way for advancements in targeted therapies.

This text is generated by artificial intelligence and may not be accurate.